Bontac attaches great importance to the development of new products and new technologies with independent intellectual property rights, and actively seeks patent protection worldwide. So far, it has filed more than 160 domestic and foreign patents, including nearly 60 international patent applications. The main coenzyme products of the company represented by NMN, NADH, NADPH and NR have obtained stable and effective patent protection in China, the United States and Japan at the same time, which escorts the related products.